SWE-NEO: Swedish NeoAdjuvant Trial Comparing Monotherapy to Combined Immunotherapy in Resectable Stage III Melanoma

Clinical trial NCT06794775 · RECRUITING

Trial details

NCT number: NCT06794775
Sponsor: Hildur Helgadottir
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Malignant Melanoma Stage III

Start date: 2025-07-10
Primary completion: 2032-04-15
Enrollment: 128

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.